NHS To Provide Brain Laser Therapy To Those With Epilepsy
The NHS has made public its intentions to provide an avant-garde laser therapy for patients with epilepsy who have not previously responded well to...
HIV Patients Avoid hepatitis B With A Three-Dose Vaccine
A three-dose series of the HEPLISAV-B vaccine protects against hepatitis B virus (HBV) in HIV patients who have not received a prior vaccination against...
Latest Study By ICR Tracks Rare Childhood Cancer Progression
The researchers discovered that liquid biopsy blood tests may detect symptoms of a malignancy that has reappeared, evaluate the severity of the condition, and...
CDC Recommends Novavax COVID Jab To Mix With Pfizer, Moderna
The Centers for Disease Control and Prevention on October 19 advised adults in the United States to take Covid boosters from Novavax, even those who...
Rare Illness Study Will Get $38mn FDA Funding Over 4 Years
A total of $38 million has been granted by the US Food and Drug Administration (FDA) in the form of 19 new grants and...
UK Clinical Trials Have Plummeted In The Past Five Years
An industry analysis on October 20th revealed that the number of clinical trials launched annually in Britain decreased by 41% between 2017 and 2021,...
Uganda Gets Novel Antibodies, Antivirals From US For Ebola
Remdesivir from Gilead Sciences and MBP134, an experimental Ebola antibody drug from Mapp Biopharmaceutical Inc., were sent by the United States last week, ending...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...